Page last updated: 2024-09-05

lapatinib and Canine Diseases

lapatinib has been researched along with Canine Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Iio, A; Kaji, K; Maeda, S; Momoi, Y; Motegi, T; Nakazawa, M; Sakai, K; Yonezawa, T	1

Trials

1 trial(s) available for lapatinib and Canine Diseases

Article	Year
Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs. Scientific reports, 2022, 01-13, Volume: 12, Issue:1 Topics: Animals; Antineoplastic Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Gene Expression Regulation, Neoplastic; Lapatinib; Male; Muscles; Piroxicam; Protein Kinase Inhibitors; Receptor, ErbB-2; Treatment Outcome; Urinary Bladder Neoplasms	2022

Article

Year

Lapatinib as first-line treatment for muscle-invasive urothelial carcinoma in dogs.

Scientific reports, 2022, 01-13, Volume: 12, Issue:1

Topics: Animals; Antineoplastic Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Gene Expression Regulation, Neoplastic; Lapatinib; Male; Muscles; Piroxicam; Protein Kinase Inhibitors; Receptor, ErbB-2; Treatment Outcome; Urinary Bladder Neoplasms

2022